Last Updated on November 17, 2022 by The Health Master
Mumbai: The Bombay High Court directed the Maharashtra government to re-examine samples of baby powder manufactured by Johnson & Johnson Pvt. Ltd. in government or government-approved laboratories.
A division bench of Justices S V Gangapurwala and S G Dige asked additional government pleader Milind More to submit names on November 16 of such labs where the tests can be conducted.
The order was passed while hearing a petition filed by the company challenging two orders of the state government, one dated September 15 canceling the license and the second dated September 20 ordering an immediate stop to the manufacturing and sale of the company’s baby powder product.
The orders were passed by the Joint Commissioner and Licensing Authority of the state Food and Drug Administration (FDA).
The state government had based its orders on the report of the Central Drug Laboratory, which found the powder contained a higher pH level than prescribed.
The High Court also asked the state to give instructions on whether it would be willing to allow the company to begin manufacturing the powder at the facility.
“Let them be allowed to manufacture, we will not permit them any handover for sale or even distribution,” the court said.
The company, in its plea, said 14 random batches from February, March, and September 2022 were tested by an independent public testing laboratory, and all were found to be well within the prescribed pH value.
The leading fast-moving consumer goods (FMCG) manufacturer said it has been making baby powder in its Mulund plant for the last 57 years, and its license was renewed in January 2020.
The company said it was facing a daily loss of Rs 2.5 crore, based on the market value of goods sold, due to the revocation of its license.
USFDA gives final approval for Cyclophosphamide capsules
Largest Pharma cluster in World to be launched in Telangana
NLEM: Anti-diabetes drugs and patented antivirals to get cheaper
IPC set to harmonise 31 General Chapters & Excipient Monographs of IP
First EC meeting of DCOIWA held at pink city Jaipur
USFDA issues Form 483 with 3 Observations to Alkem
Injections for Diabetes, Cancer could become unnecessary soon
USFDA issued OAI Status to Sun Pharma
Pharmacy Inspectors to be appointed soon
Latest Notifications regarding Pharmaceuticals
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
